Par Drugs & Chemical Stock Screener | Share Price & Fundamental Analysis

Share Price NSE
₹92.03
▼ -3.66 (-3.82%)
2026-03-02 00:00:00
Track Par Drugs & Chemical share price live with TickJournal's free stock screener. Analyze Par Drugs & Chemical share price history trends and compare 52-week high low levels. Calculate PAR stock fair value using fundamental analysis and view live share price charts. Determine Par Drugs & Chemical share intrinsic value and compare it with current PAR share price. Record your Par Drugs & Chemical trades in TickJournal's free trading journal and track your portfolio performance.
EPS (TTM) ₹10.86
Dividend Yield -
Debt to Equity -
PAR 52 Week High ₹110.81
Par Drugs & Chemical 52 Week Low ₹86.30
Operating Margin 13.00%
Profit Margin 9.80%
PAR Revenue (TTM) ₹102.00
EBITDA ₹17.00
Net Income ₹10.00
Total Assets ₹119.00
Total Equity ₹99.00

Par Drugs & Chemical Share Price History - Stock Screener Chart

Screen PAR historical share price movements with interactive charts. Analyze price trends and patterns.

Par Drugs & Chemical Company Profile - Fundamental Screener

Screen Par Drugs & Chemical company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PAR shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE04LG01015

Par Drugs & Chemical Balance Sheet Screener

Screen PAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017
Assets
Total Assets 119 102 89 79 76 60 51 54 56
Current Assets 55 60 49 44 41 24 14 14 14
Fixed Assets 39 41 38 34 30 34 36 39 42
Liabilities
Total Liabilities 119 102 89 79 76 60 51 54 56
Current Liabilities 4 4 4 4 8 9 10 16 17
Non-Current Liabilities 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 99 86 71 60 52 41 29 21 20
Share Capital 12 12 12 12 6 6 5 9 9
Reserves & Surplus 87 73 59 48 46 35 25 13 11

Par Drugs & Chemical Income Statement Screener - Profit & Revenue Analysis

Screen Par Drugs & Chemical income statement and profit fundamentals. Analyze PAR quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Par Drugs & Chemical share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March
Revenue 102 103 96 96 75 61 56 46 42 49
Expenses 85 82 73 78 59 45 46 38 34 40
EBITDA 17 22 23 18 16 16 10 8 8 9
Operating Profit % 13.00% 19.00% 24.00% 19.00% 22.00% 26.00% 17.00% 18.00% 19.00% 18.00%
Depreciation 4 4 3 3 3 3 3 3 3 3
Interest 0 0 0 0 1 1 1 2 2 3
Profit Before Tax 13 18 20 15 13 15 6 3 3 3
Tax 3 5 5 4 4 3 1 1 1 2
Net Profit 10 13 15 11 9 12 5 3 2 2
EPS 7.90 10.86 11.78 9.21 7.49 18.87 7.75 5.60 5.64 6.50

Par Drugs & Chemical Cash Flow Screener - Liquidity Fundamentals

Screen PAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 16 20 13 8 12 8 2 4 9 7
Investing Activities -25 -6 -7 -3 0 -2 0 -1 -2 0
Financing Activities 0 0 0 -10 2 1 -2 -4 -8 -6
Net Cash Flow -9 14 6 -5 14 7 0 0 -1 1

Par Drugs & Chemical Shareholding Pattern Screener

See Par Drugs & Chemical shareholding pattern with promoter, FII, and DII holdings. Check Par Drugs & Chemical promoter holding and ownership changes for PAR on TickJournal.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar
Promoter Holding 73.37% 73.37% 73.37% 74.21% 74.21% 73.37% 73.37% 74.21%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 20.30% 20.26% 20.27% 20.46% 20.09% 19.42% 22.86% 22.05%
Other Holding 6.33% 6.37% 6.37% 5.34% 5.71% 7.21% 3.77% 3.74%
Shareholder Count 15,472 14,887 14,280 7,403 8,022 8,757 17,199 5,585

Par Drugs & Chemical Share Dividend Screener - Share Yield Analysis

Check Par Drugs & Chemical dividend history with payout and yield data. View Par Drugs & Chemical dividend details including ex-dates and amounts for PAR stock.
Period Dividend Per Share Dividend Yield
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹2.50 4.04%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%
2016-March ₹0.00 0.00%

Par Drugs & Chemical Stock Index Membership

See which indices include Par Drugs & Chemical stock. Check PAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Par Drugs & Chemical is not part of any tracked indices.
Only major market indices are tracked in our system.

Par Drugs & Chemical Market Events Screener - Corporate Actions

Get Par Drugs & Chemical corporate actions including splits, bonuses, and buybacks. Check Par Drugs & Chemical stock events that may affect PAR share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 2.55%
2025-12-31 2025-12-31 Extraordinary General Meeting NA -14.97%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -4.43%
2025-08-07 2025-08-07 Quarterly Result Announcement NA -8.56%
2025-05-08 2025-05-08 Quarterly Result Announcement NA -0.65%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -14.79%
2025-02-12 2025-02-12 Extraordinary General Meeting NA -9.70%
2025-02-05 2025-02-05 Extraordinary General Meeting NA -2.49%
2024-10-22 2024-10-22 Quarterly Result Announcement NA 5.27%
2021-11-22 2021-11-23 Dividend ₹ 1.25 /share -32.38%
2021-04-27 2021-04-28 Bonus 1:1 3.44%

Par Drugs & Chemical Competitors Screener - Peer Comparison

Screen PAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 416,764 40.16 54,729 9.71% 10,980 41.99
Divis Laboratories 172,462 69.16 9,712 18.67% 2,191 54.95
Torrent Pharmaceuticals 129,770 60.40 11,539 6.99% 1,911 64.03
Cipla 120,864 22.30 28,410 7.12% 5,291 43.36
Dr Reddys Laboratories 105,645 18.66 33,741 16.73% 5,725 50.22
Lupin 96,238 22.21 22,910 13.74% 3,306 58.72
Zydus Life Science 92,352 18.57 23,511 18.55% 4,615 41.66
Mankind Pharma 90,530 51.90 12,744 20.90% 2,007 47.28
Aurobindo Pharma 70,358 20.66 32,346 9.43% 3,484 55.09
Alkem Laboratories 66,550 27.75 13,458 3.70% 2,216 44.89

Par Drugs & Chemical Company Announcements - News Screener

Screen PAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2025-12-13 Action(s) taken or orders passed View
2025-11-14 Copy of Newspaper Publication View
2025-11-13 Outcome of Board Meeting View
2025-11-13 Outcome of Board Meeting View
2025-11-13 Updates View
2025-11-13 Outcome of Board Meeting View
2025-11-03 Copy of Newspaper Publication View
2025-10-27 Action(s) taken or orders passed View
2025-10-08 Certificate under SEBI (Depositories and Participants) Regulations, 2018 View
2025-10-03 Updates View
2025-09-29 Appointment View
2025-09-29 Trading Window View
2025-09-28 Appointment View
2025-09-28 Appointment View
2025-09-28 Appointment View
2025-09-28 Appointment View
2025-09-28 Shareholders meeting View
2025-09-28 Appointment View
2025-09-27 Shareholders meeting View
2025-09-27 General Updates View